BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25623860)

  • 21. Transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: a retrospective study of a 5-year experience in a single institution.
    Si Y; Hu X; Du H; Lou W; Zhang H; Cao F; Yu W; Wang W; Jin K
    Hepatogastroenterology; 2013 Sep; 60(126):1405-8. PubMed ID: 23933931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinoma.
    Radunz S; Saner FH; Treckmann J; Rekowski J; Theysohn JM; Müller S; Best J; Sotiropoulos GC; Paul A; Benkö T
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28836737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
    Cascales-Campos PA; Ramírez P; Lopez V; Gonzalez R; Saenz-Mateos L; Llacer E; Sánchez Bueno F; Robles R; Pons JA; Capel A; Frutos L; Navarro JL; Muñoz-Ramon P; Parrilla P
    Transplant Proc; 2015 Oct; 47(8):2374-6. PubMed ID: 26518931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
    Pérez Saborido B; Meneu JC; Moreno E; García I; Moreno A; Fundora Y
    Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
    Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors.
    Shi HY; Wang SN; Wang SC; Chuang SC; Chen CM; Lee KT
    J Surg Oncol; 2014 Apr; 109(5):487-93. PubMed ID: 24293372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma.
    Kim YI; Park JW; Kwak HW; Kim BH; Lee JH; Lee IJ; Kim TH; Kim SH; Koh YH; Kim HB; Kim CM
    Liver Int; 2014 Sep; 34(8):1278-86. PubMed ID: 24649961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
    AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.
    Seki A; Hori S; Kobayashi K; Narumiya S
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):557-65. PubMed ID: 20821211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
    Nicolini A; Martinetti L; Crespi S; Maggioni M; Sangiovanni A
    J Vasc Interv Radiol; 2010 Mar; 21(3):327-32. PubMed ID: 20097098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.
    Harnois DM; Steers J; Andrews JC; Rubin JC; Pitot HC; Burgart L; Wiesner RH; Gores GJ
    Liver Transpl Surg; 1999 May; 5(3):192-9. PubMed ID: 10226109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Hepatic Artery Complications After Liver Transplantation in Patients Who Received Pretransplant Transarterial Chemoembolization Therapy: A Single-Center Experience.
    Selim M; Hohenwalter EJ; Rilling WS; Hong JC
    Transplant Proc; 2023 Sep; 55(7):1631-1637. PubMed ID: 37391331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
    Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.
    Lesurtel M; Müllhaupt B; Pestalozzi BC; Pfammatter T; Clavien PA
    Am J Transplant; 2006 Nov; 6(11):2644-50. PubMed ID: 16939518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas.
    Golfieri R; Cappelli A; Cucchetti A; Piscaglia F; Carpenzano M; Peri E; Ravaioli M; D'Errico-Grigioni A; Pinna AD; Bolondi L
    Hepatology; 2011 May; 53(5):1580-9. PubMed ID: 21351114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
    Zhou WP; Lai EC; Li AJ; Fu SY; Zhou JP; Pan ZY; Lau WY; Wu MC
    Ann Surg; 2009 Feb; 249(2):195-202. PubMed ID: 19212170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.